Lunai Bioworks Inc.【LNAI】
| Jun 30, 2018 | Jun 30, 2019 | Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 |
|---|
| Cash | 16 | 12 | 21 | 9 | 2 | 220,467 |
|---|
| Insurance receivable | - | - | - | - | - | 1 |
|---|
| Prepaids and other assets | - | - | - | 392,996 | 690,925 | 668,929 |
|---|
| Total Current Assets | 16 | 12 | 21 | 10 | 3 | 2 |
|---|
| Property and equipment, net | 27,402 | 687,517 | 719,364 | 586,536 | 508,989 | 482,121 |
|---|
| Definite life intangible assets, net | 152 | 93,299 | 65,906 | 44,268 | 39,676 | 30,043 |
|---|
| Indefinite life intangible assets, net | - | 155 | 155 | 62 | 43 | - |
|---|
| Goodwill | 12 | 12 | 12 | 12 | 12 | 159 |
|---|
| Deposits and other assets | 137,550 | 137,550 | 20,984 | 68,635 | 21,741 | 19,849 |
|---|
| Operating lease right-of-use assets | - | - | 1 | 1 | 913,985 | 1 |
|---|
| Total Other Assets | - | - | 168 | 74 | 55 | 161 |
|---|
| TOTAL ASSETS | 180 | 180 | 190 | 85 | 58 | 163 |
|---|
| Accounts payable – trade | 571,809 | 538,563 | 320,559 | 1 | 5 | 9 |
|---|
| Accrued expenses | 66,913 | 336,853 | 1 | 1 | 723,173 | 5 |
|---|
| Other current liabilities | - | - | 90,602 | 220,685 | 184,733 | 295,361 |
|---|
| Contingent consideration liability | - | - | - | - | - | 12 |
|---|
| Convertible notes payable | - | - | 1 | - | - | 245,000 |
|---|
| Current portion of operating lease liabilities | - | - | 292,409 | 253,636 | 193,422 | 493,553 |
|---|
| Notes payable – related parties, net | - | - | - | - | - | 2 |
|---|
| Total Current Liabilities | 873,722 | 1 | 2 | 6 | 11 | 30 |
|---|
| Operating lease liabilities, net of current portion | - | - | 1 | 985,699 | 775,587 | 842,389 |
|---|
| Total Non-Current Liabilities | 23 | 6 | 15 | 6 | 775,587 | 842,389 |
|---|
| Total Liabilities | 24 | 7 | - | 12 | 12 | 31 |
|---|
| Common stock, par value $0.0001, 350,000,000 shares authorized, 155,027,245 shares issued and outstanding at June 30, 2024; 63,698,144 shares issued and outstanding at June 30, 2023 | 3,616 | 4,527 | 5,222 | 5,302 | 6,371 | 15,504 |
|---|
| Additional paid-in capital | 193 | 226 | 266 | 277 | 291 | 457 |
|---|
| Accumulated deficit | -37,595,389 | -52,771,840 | -90,911,805 | -204,345,197 | -244,029,253 | -324,679,425 |
|---|
| Accumulated other comprehensive (loss) | 205,680 | 101,818 | -10,834 | -30,436 | -29,882 | -170,846 |
|---|
| Total Stockholders’ Equity | 156 | 173 | 175 | 73 | 47 | 132 |
|---|
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | 180 | 180 | 190 | 85 | 58 | 163 |
|---|